Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

January 16, 2024

Study Completion Date

January 16, 2024

Conditions
Treatment Complication
Interventions
PROCEDURE

autologous bone marrow aspirate concentrate by centrifugation

"50 cc bone marrow aspirates concentrate after centrifugation with final volume up to 7 cc.~Assess total nucleated count and viability. Bone marrow aspirate concentrate is chosen as a source of mesenchymal stem cells, because of safe and easy procedure.~Bone marrow aspiration is done under local or general anesthesia, depending on the individual case. Around 50 cc of bone marrow is aspirated from the posterior iliac crest after proper sterilization using bone marrow aspiration needle (size according to the patient) and collected in heparinized syringes. Mononuclear cells (MNCs) are obtained by centrifugation. The isolated MNCs are checked for viability manually and confirmed on automated cell count machine.~The separated MNCs is administered intra-articularly immediately after centrifugation."

Trial Locations (1)

964

Ministry of Health, Baghdad

All Listed Sponsors
lead

Global Stem Cell Center, Baghdad

INDUSTRY